YAĞIN, F. H. Et Al. 2023. Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics. Metabolites , vol.13, no.12 .

YAĞIN, F. H., YAŞAR, Ş., GÖRMEZ, Y., Yagin, B., Pinar, A., Alkhateeb, A., ... Ardigò, L. P.(2023). Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics. Metabolites , vol.13, no.12.

YAĞIN, FATMA Et Al. "Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics," Metabolites , vol.13, no.12, 2023

YAĞIN, FATMA H. Et Al. "Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics." Metabolites , vol.13, no.12, 2023

YAĞIN, F. H. Et Al. (2023) . "Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics." Metabolites , vol.13, no.12.

@article{article, author={FATMA HİLAL YAĞIN Et Al. }, title={Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics}, journal={Metabolites}, year=2023}